Dostarlimab (TSR-042) is a programmed cell death protein 1 (PD-1) receptor immune checkpoint inhibitor that blocks interactions with PD-L1 and PD-L2, used in the study of endometrial cancer.
Purity:
>95%
CAS Number:
[2022215-59-2]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
